Acitretin: Clinical Trials

34 trials of Acitretin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 6 unknown, 4 withdrawn, 3 terminated. 16 Phase 4, 7 Phase 2, 5 Not applicable, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 416Completed 5, Unknown 4, Withdrawn 3, Recruiting 2, Not yet recruiting 1, Terminated 1
Phase 27Completed 4, Not yet recruiting 1, Terminated 1, Unknown 1
Not applicable5Completed 3, Terminated 1, Unknown 1
Phase 12Completed 1, Withdrawn 1
Phase 32Completed 2

Follow Acitretin: new trials by email Literature Review of Acitretin trials Research Report on Acitretin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Tofacitinib and Acitretin Capsules., Acitretin Capsules. - Primary Cutaneous Amyloidosis
Phase 4RecruitingArmy Medical University, China562025-03-012025-08-13
Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa
Apremilast, Acitretin - Hidradenitis Suppurativa
Phase 4CompletedHayat Abad Medical Complex, Peshawar702024-12-222026-07-16
Systemic Treatment Options for Generalized Lichen Planus
Methotrexate (drug), Acitretin - Lichen Planus
Phase 2Not yet recruitingSheikh Zayed Medical College1242024-12-102024-12-18
Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
secukinumab, Methotrexate, Cyclosporin A - Plaque Psoriasis
Phase 4Not yet recruitingSingapore General Hospital402024-01-012022-11-25
Plexin B2 Gene Expression and Polymorphisms in Psoriasis
Narrow band Ultraviolet B phototherapy group, Acitretin group, Acitretin plus Narrow band Ultraviolet B phototherapy group - Psoriasis Vulgaris
Phase 1CompletedSouth Valley University2002021-09-012023-09-21
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
Acitretin 25Mg Cap, Narrowband ultraviolet B - Psoriasis
Phase 4UnknownSouth Valley University302021-06-052022-06-02
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Ixekizumab, Methotrexate, Cyclosporin A - Plaque Psoriasis
Phase 4RecruitingSingapore General Hospital402020-12-102022-11-25
Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation
Acitretin, Narrow band ultraviolet B - Hyperlipidemias, Xerosis
Not applicableUnknownCairo University202020-01-012021-07-22
RA Effect on Cell Surface Molecules in Vivo
Acitretin - HIV Infections
Phase 1WithdrawnOttawa Hospital Research Institute2019-01-072020-03-04
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
Narrowband Ultraviolet B, Acitretin - Psoriasis
Phase 4CompletedMahmoud Ahmed Ali Ahmed602018-09-012022-01-24
Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules
Acitretin Capsules - Psoriasis Vulgaris
Phase 2UnknownCentral South University5002015-12-012016-03-22
Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles
Excimer laser, Acitretin - Psoriasis, Skin or Nails
Phase 4TerminatedIcahn School of Medicine at Mount Sinai22014-06-012021-03-10
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Acitretin, Vemurafenib - Malignant Melanoma
Phase 2TerminatedUniversity of Arizona22013-12-012018-12-26
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Methotrexate, Ustekinumab, Etanercept - Psoriasis, Inflammation
CompletedUniversity Hospitals Cleveland Medical Center262013-04-012017-10-13
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
Methotrexate, Cyclosporins, fumaric acid - Psoriasis
CompletedJochen Schmitt.12013-03-012017-08-11
Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis
Total glucosides of paeony & Acitretin Capsules, Acitretin Capsules - Psoriasis
Not applicableCompletedXijing Hospital1082013-02-012014-07-15
Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis
Acitretin - Chronic Hand Dermatitis
Phase 2 / Phase 3CompletedInnovaderm Research Inc.92012-03-012014-07-24
Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
Triptergium Wilfordii, Acitretin - Psoriasis Vulgaris
Phase 4UnknownMinistry of Health, China7202011-09-012011-09-29
Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)
Acitretin - Skin Rash
Phase 4WithdrawnUniversity of Pittsburgh2010-11-012013-01-16
Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?
Acitretin 17.5 mg/day - Psoriasis
Phase 4UnknownFrankel, Amylynne, M.D.202010-10-012011-06-22

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Psoriasis (17)  ·  Carcinoma, Basal Cell (2)  ·  HIV Infections (2)  ·  AIDS-Related Complex (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alzheimer Disease (1)  ·  Amyloidosis, Primary Cutaneous (1)  ·  Carcinoma, Squamous Cell (1)  ·  Depression (1)  ·  Exanthema (1)  ·  Hidradenitis Suppurativa (1)  ·  Hyperlipidemias (1)  ·  Inflammation (1)  ·  Lichen Planus (1)  ·  Liver Diseases (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  Singapore General Hospital (2)  ·  South Valley University (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Army Medical University, China (1)  ·  Cairo University (1)  ·  Central South University (1)  ·  Frankel, Amylynne, M.D. (1)  ·  Günther Hofbauer (1)  ·  Hayat Abad Medical Complex, Peshawar (1)  ·  Hoffmann-La Roche (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Innovaderm Research Inc. (1)  ·  Istituti Fisioterapici Ospitalieri (1)  ·  Jochen Schmitt. (1)

Countries

United States (9)  ·  China (4)  ·  Egypt (4)  ·  India (2)  ·  Italy (2)  ·  Pakistan (2)  ·  Singapore (2)  ·  Canada (1)  ·  Germany (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Mark R. Pittelkow, MD (2)  ·  Sunil Dogra, MD (2)  ·  Ying Ying Leung, MD (2)  ·  Andreas Fellgiebel, PD Dr. (1)  ·  Anthony D Ormerod, Consultant (1)  ·  Antonella Tosti, MD (1)  ·  Eisa Hegazy, Prof. (1)  ·  Giampiero Girolomoni (1)  ·  Jerry Tan, MD, FRCPC (1)  ·  Jochen Schmitt, MD, MPH (1)  ·  Jonathan B Angel, MD, FRCPC (1)  ·  Kristina C Duffin, MD (1)  ·  Larisa J Geskin, MD (1)

Results publications

PMID 19380660, PMID 21882176, PMID 27455955

NIH funding

2009 (1), P30CA015083 (1)